LAWFUEL – Intellectual Property News – The Court of Appeal dismissed an appeal brought by Kent, a parallel importer, against a High Court summary judgment decision to the effect that the presence of a CE mark on a pharmaceutical product did not indicate the manufacturer’s consent to the sale of the product within Europe. The case confirms the difficulty in proving the trade mark owner’s consent to importation and highlights the problems faced by importers who may purchase stock in good faith. However, given that the trade mark owner had expressly provided the goods for a trial in South America, demonstrating consent was never likely to have been easy on these facts.
Read More
What Car Accident Laws Mean for Injury Victims
 November 4, 2025 
Building a Strong Case: How Employees Can Prove Workplace Harassment
 November 4, 2025 
How Estate Planning Protects Your Minor Children
 November 3, 2025 
What The Probate Process Really Involves: A Legal Deep Dive
 October 31, 2025 
Legora Becomes LawTech Darling With $1.8 Billion Valuation
 October 31, 2025